A S O V I S U A L A B S T R A C T
ASO Visual Abstract: End-of-Life Hospice Utilization and Medicare Expenditures Among Patients Dying from Hepatocellular Carcinoma
Daniel R. Rice, BS, J. Madison Hyer, MS, Adrian Diaz, MD, MS, MPH, and Timothy M. Pawlik, MD, MPH, PhD, FACS, FRACS (Hon.)
Division of Surgical Oncology, Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH USA
The objective of our study was to characterize health- care expenditures and hospice utilization among patients with HCC using a large, national database (https://rdcu.b e/chJfX). Minority patients and individuals with hepato- cellular carcinoma residing in high-vulnerability areas were less likely to use hospice. Patients who utilized hos- pice at end of life had a reduction in inpatient and outpatient Medicare claims.
End of Life Hospice Utilization and Medicare Expenditures Among Patients Dying from Hepatocellular Carcinoma
2 out of 3 patients dying of HCC utilized hospice services at the end of life
Racial/ethnic minorities were less
likely to utilize hospice.
Patients with higher social vulnerability indices were less likely
to utilize hospice.
OR 0.66 OR 0.97
Rice et al. Ann Surg Oncol.
Visual Abstract @danrice90 @timpawlik for @AnnSurgOncol
Hospice utilization was associated with decreased end-of-life expenditures
$10,000 decrease in inpatient expenditures
$1,300 decrease in outpatient expenditures
ANNALS OF SURGICAL ONCOLOGY
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
FUNDING There was no financial support for this study.
ÓSociety of Surgical Oncology 2021
T. M. Pawlik, MD, MPH, PhD, FACS, FRACS (Hon.) e-mail: tim.pawlik@osumc.edu
Ann Surg Oncol (2021) 28:5425
https://doi.org/10.1245/s10434-021-09971-3
